Diagnostic Tests for Disease Risk

About Precision Quantomics

Precision Quantomics is a private, early-stage diagnostics and tools company founded in 2019 and headquartered in Cambridge, Massachusetts. It leverages advanced mass spectrometry-based proteomics to create quantitative assay kits and services that help predict drug-induced liver injury (DILI), drug metabolism, and transport, aligning with regulatory shifts toward non-animal testing. The company operates a hybrid business model, selling proprietary assay kits (e.g., MSQ-DILI, MSQ-CYP) while offering contract services and consultancy, primarily serving pharmaceutical and biotech clients. It is currently in a pre-revenue or early-revenue stage, focusing on platform validation and market adoption.